Rosuvastatin products. Medical specialism: Dispensing GP practices and 1 National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall
2024 are being recalled due to potential microbiological contamination. For Rosuvastatin 5 mg film-coated tablets-PIL Rosuvastatin 10 mg film
Letters and medicine recalls sent to healthcare professionals in July 2024. A simvastatin, rosuvastatin and pitavastatin (singl Therapeutic area
Letters and medicine recalls sent to healthcare professionals in July 2024. A rosuvastatin and pitavastatin (singl Therapeutic area: Cardiovascular
Crestor (rosuvastatin) Ezallor Sprinkle (rosuvastatin) Roszet (rosuvastatin and ezetimibe) Rhabdomyolysis. Radiation recall phenomenon. FDA is evaluating the need for regulatory action.
Crestor rosuvastatin'). Brand Promotions (supplied to AstraZeneca). Recall published Recall letters will be dispatched by Astra Zeneca
Australia: BTC Rosuvastatin 10 mg tablets: Recall - potential missing blister sheets Content last updated: Monday, . back. 2024
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection.
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection. The latest recall number for this product is D- and the recall is currently terminated as of .
Comments